VERA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.32 USD | -2.39% |
|
-4.88% | +168.66% |
| May. 10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
| May. 09 | Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Vera Therapeutics, Inc.
4c14f9.hVO58JjcXVnvN4_VY_qs-vJZVxFANvQpYhkzhSNq__s.qAuMofa3Kz_YBu6EOcrWsL0xA3saR6NvIXxltFMEmInxKvqpwJ8fM7pDvw~9ec2b3b8fcaf4fe9599a71218de6107c
Upcoming events on Vera Therapeutics, Inc.
Past events on Vera Therapeutics, Inc.
| 2024-05-09 08:00 am | Q1 2024 Earnings Release |
| 2024-03-20 07:30 am | Q4 2023 Earnings Release |
| 2024-03-04 02:10 pm | TD Cowen Health Care Conference |
| 2024-03-04 09:10 am | TD Cowen Health Care Conference - Panel |
| 2024-02-07 02:00 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-25 08:00 am | R&D Day |
| 2024-01-09 06:00 pm | JPMorgan Healthcare Conference |
| 2023-11-30 10:50 am | Evercore ISI HealthCONx Conference |
| 2023-11-09 08:00 am | Q3 2023 Earnings Release |
| 2023-11-06 09:50 am | Guggenheim Securities Inflammation & Immunology Conference |
| 2023-11-04 10:00 am | American Society of Nephrology Kidney Conference - Poster- SA-PO884 |
| 2023-11-04 10:00 am | American Society of Nephrology Kidney Conference - Poster - SA-PO887 |
| 2023-11-02 10:00 am | American Society of Nephrology Kidney Conference - Poster - INFO17-TH |
| 2023-09-27 11:25 am | Cantor Global Healthcare Conference |
| 2023-09-20 02:15 pm | Stifel Immunology and Inflammation Virtual Summit |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-09-05 | Citi BioPharma Conference |
| 2023-08-10 08:00 am | Q2 2023 Earnings Release |
| 2023-06-20 08:00 am | Investor Meeting |
| 2023-06-16 | European Renal Association Congress |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -90,1 -75,8 -18.81% | -97,9 -97,0 -0.95% | -120 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -34,4 -28,6 -20.16% | -90,9 -81,8 -11.16% | -102 -98,9 -3.15% | -125 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -32,6 -27,7 -17.78% | -89,1 -81,1 -9.86% | -96,0 -94,3 -1.82% | -122 |
|
Net income Million USD | Released Forecast Spread | -53,4 | -32,6 -27,7 -17.78% | -89,1 -81,1 -9.76% | -96,0 -94,3 -1.83% | -122 |
|
EPS USD | Released Forecast Spread | -14,4 | -2,43 -2,01 -20.9% | -3,35 -3,01 -11.3% | -2,25 -2,18 -3.4% | -2,33 |
| Announcement Date | 19/03/21 | 28/03/22 | 28/03/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -15,2 -19,0 20.19% | -25,4 -22,0 -15.44% | -33,0 -18,0 -83.24% | -31,8 -19,0 -67.18% | -22,9 -25,0 8.24% | -25,9 -22,0 -17.55% | -28,0 | -29,0 | -31,0 | -32,0 | ||||
|
EBIT Million USD | Released Forecast Spread | -17,0 -17,8 4.11% | -15,1 -18,5 18.75% | -25,2 -19,5 -29.51% | -33,6 -24,4 -37.83% | -31,3 -25,1 -24.39% | -22,0 -27,9 21.27% | -21,8 -24,8 12.35% | -27,0 -23,9 -13.17% | -31,1 -28,0 -11.13% | -30,5 | -31,7 | -33,1 | -35,5 | -37,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,1 -17,9 4.74% | -14,9 -18,5 19.77% | -24,7 -19,5 -26.38% | -32,4 -24,5 -32.24% | -30,1 -25,4 -18.23% | -20,2 -27,8 27.52% | -20,1 -24,5 17.92% | -25,7 -23,6 -8.92% | -27,8 | -30,2 | -31,6 | -33,1 | -33,2 | -35,2 |
|
Net income Million USD | Released Forecast Spread | -17,1 -17,9 4.74% | -14,9 -18,5 19.77% | -24,7 -19,5 -26.38% | -32,4 -24,5 -32.24% | -30,1 -25,4 -18.23% | -20,2 -27,8 27.52% | -20,1 -24,5 17.92% | -25,7 -23,6 -8.93% | -28,4 -27,9 -1.82% | -30,2 | -31,6 | -33,1 | -33,2 | -35,2 |
|
EPS USD | Released Forecast Spread | -0,71 -0,64 -10.65% | -0,55 -0,74 25.48% | -0,91 -0,72 -26.1% | -1,19 -0,88 -34.65% | -0,80 -0,60 -32.3% | -0,46 -0,69 33.71% | -0,45 -0,53 15.31% | -0,58 -0,51 -14.19% | -0,56 -0,53 -5.74% | -0,57 | -0,59 | -0,61 | -0,59 | -0,60 |
| Announcement Date | 16/05/22 | 10/08/22 | 09/11/22 | 28/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 20/03/24 | 09/05/24 | - | - | - | - | - |
| 2024-05-13 | BELITE BIO, INC: Q1 2024 Earnings Release |
| 2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
| 2024-05-13 | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-15 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
Past sector events for Vera Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VERA Stock
- Calendar Vera Therapeutics, Inc.